CV Sciences Inc (CVSI)

[sleuth100]

Encouraging to see the company(APIRx Pharmaceuticals) owner of a similar patent that combines CBD and nicotine in a gum, has been purchased by NASDAQ company Incannex for about 95M..

"Globally, the market for nicotine medicated chewing gums for smoking cessation generates in excess of US$5bn in sales per annum.

The chewing gum delivery method works by releasing nicotine directly into the blood stream through the lining of the mouth to reduce cravings for a cigarette.

While it’s a mature industry, data shows that nicotine gum products still only assist around 15% of the smokers to quit for good.

In that context, the Incannex board believes both of APIRx’s CanQuit treatments have the capacity to materially disrupt the global nicotine gum market. They may achieve this by combining nicotine and CBD to potentially better assist smokers to quit smoking"